MX371007B - Vectores de expresión que comprenden un promotor de citomegalovirus quimérico y secuencias mejoradoras. - Google Patents
Vectores de expresión que comprenden un promotor de citomegalovirus quimérico y secuencias mejoradoras.Info
- Publication number
- MX371007B MX371007B MX2015002888A MX2015002888A MX371007B MX 371007 B MX371007 B MX 371007B MX 2015002888 A MX2015002888 A MX 2015002888A MX 2015002888 A MX2015002888 A MX 2015002888A MX 371007 B MX371007 B MX 371007B
- Authority
- MX
- Mexico
- Prior art keywords
- cytomegalovirus
- sequence
- human
- expression vectors
- nucleic acid
- Prior art date
Links
- 239000013604 expression vector Substances 0.000 title abstract 5
- 241000701022 Cytomegalovirus Species 0.000 title abstract 3
- 108700028146 Genetic Enhancer Elements Proteins 0.000 title abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 5
- 150000007523 nucleic acids Chemical group 0.000 abstract 5
- 230000001105 regulatory effect Effects 0.000 abstract 4
- 241000701024 Human betaherpesvirus 5 Species 0.000 abstract 3
- 241000701033 Simian cytomegalovirus Species 0.000 abstract 3
- 101900065606 Human cytomegalovirus Immediate early protein IE1 Proteins 0.000 abstract 2
- 241000701029 Murid betaherpesvirus 1 Species 0.000 abstract 2
- 241001529936 Murinae Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 238000011144 upstream manufacturing Methods 0.000 abstract 2
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se refiere a vectores de expresión para la expresión heteróloga de una secuencia de interés de ácido nucleico en células de mamíferos, los vectores comprendiendo una secuencia reguladora promotora quimérica estando enlazado operablemente a una secuencia de ácido nucleico que va ser expresado, en donde la secuencia reguladora promotora quimérica comprende una secuencia promotora de citomegalovirus derivada de citomegalovirus murino o de citomegalovirus humano y estando enlazado operablemente a un sitio de inicio transcripcional de la secuencia de ácido nucleico que va ser expresada; y una secuencia mejoradora y/o de región hacia arriba de citomegalovirus derivada de citomegalovirus humano y/o de simio, en donde la secuencia mejoradora y/o de región hacia arriba está localizado a 5' de y enlazado operablemente a la secuencia promotora murino o de humano, y en donde la secuencia reguladora promotora quimérica comprende elementos de secuencia que están derivados de por lo menos dos del grupo que consiste de citomegalovirus murino, citomegalovirus humano y de citomegalovirus de simio. En las incorporaciones particulares, la secuencia reguladora de promotora quimérica comprende elementos e secuencia derivados de promotor lE 1 de citomegalovirus humano o murino y de la región lE 1 de citomegalovirus de simio. La invención también se refiere a células anfitrionas de mamífero transfectadas con tales vectores de expresión, a un método para la expresión heteróloga de una secuencia de ácido nucleico en una célula anfitriona de mamífero mediante el empleo de tales vectores de expresión, y al uso de tales vectores de expresión para la expresión heteróloga de una secuencia de ácido nucleico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12185728.8A EP2711426B1 (en) | 2012-09-24 | 2012-09-24 | Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences |
| PCT/EP2013/069715 WO2014044845A1 (en) | 2012-09-24 | 2013-09-23 | Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015002888A MX2015002888A (es) | 2015-10-14 |
| MX371007B true MX371007B (es) | 2020-01-09 |
Family
ID=46888330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015002888A MX371007B (es) | 2012-09-24 | 2013-09-23 | Vectores de expresión que comprenden un promotor de citomegalovirus quimérico y secuencias mejoradoras. |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US9777290B2 (es) |
| EP (2) | EP2711426B1 (es) |
| JP (2) | JP6162246B2 (es) |
| KR (1) | KR101757083B1 (es) |
| CN (1) | CN104718296B (es) |
| AU (1) | AU2013320157B2 (es) |
| BR (1) | BR112015005604B1 (es) |
| CA (1) | CA2880750C (es) |
| DK (2) | DK2711426T3 (es) |
| EA (1) | EA033008B1 (es) |
| ES (2) | ES2540753T3 (es) |
| HU (2) | HUE026516T2 (es) |
| IL (1) | IL237171B (es) |
| MX (1) | MX371007B (es) |
| PL (2) | PL2711426T3 (es) |
| SG (1) | SG11201502243YA (es) |
| TR (1) | TR201816314T4 (es) |
| TW (1) | TWI507526B (es) |
| WO (1) | WO2014044845A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE026516T2 (en) | 2012-09-24 | 2016-06-28 | Lonza Biologics Plc | Expression vectors containing chimeric cytomegalovirus promoter and enhancer sequences |
| US10106817B2 (en) * | 2013-02-14 | 2018-10-23 | The J. David Gladstone Institutes | Compositions and methods of use thereof for identifying anti-viral agents |
| JP6566536B2 (ja) * | 2014-06-16 | 2019-08-28 | 国立大学法人山口大学 | フォワードプライマー |
| GB201603577D0 (en) * | 2016-03-01 | 2016-04-13 | Oxford Genetics Ltd | Promoter |
| US11001858B2 (en) * | 2016-06-20 | 2021-05-11 | Janssen Vaccines & Prevention B.V. | Potent and balanced bidirectional promoter |
| US12054733B2 (en) | 2017-06-16 | 2024-08-06 | Lonza Ltd | Universal self-regulating mammalian cell line platform for the production of biologics |
| CN109988759A (zh) * | 2017-12-29 | 2019-07-09 | 上海细胞治疗研究院 | 一种在t细胞中具有高转录活性的嵌合启动子 |
| US12077786B2 (en) * | 2018-02-02 | 2024-09-03 | Lonza Ltd | Methods of cell selection and modifying cell metabolism |
| WO2020034097A1 (en) * | 2018-08-14 | 2020-02-20 | Wuxi Biologics (Shanghai) Co., Ltd. | Transcriptional regulatory element and its use in enhancing the expression of exogenous protein |
| KR102937659B1 (ko) * | 2020-02-19 | 2026-03-10 | 우시 바이올로직스 아일랜드 리미티드 | 강화된 발현 시스템 및 그 사용방법 |
| WO2022204067A1 (en) * | 2021-03-24 | 2022-09-29 | Dna Twopointo Inc. | Tetracycline-inducible expression systems |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4963481A (en) * | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| GB8723818D0 (en) | 1987-10-10 | 1987-11-11 | Brico Eng | Sintered materials |
| FI884924A7 (fi) * | 1987-10-28 | 1989-04-29 | Oncogen | Yhdistelmä-DNA-tekniikalla tuotettuja ihmisimmunoglobuliineja |
| GB8900483D0 (en) | 1989-01-10 | 1989-03-08 | Celltech Ltd | Recombinant dna method |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| US20020106635A1 (en) | 1998-05-27 | 2002-08-08 | Bruce Freimark | Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
| EP1297146A2 (en) | 2000-06-23 | 2003-04-02 | Maxygen, Inc. | Novel chimeric promoters |
| US20030157641A1 (en) * | 2001-11-16 | 2003-08-21 | Idec Pharmaceuticals Corporation | Polycistronic expression of antibodies |
| GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| ATE399872T1 (de) | 2003-03-11 | 2008-07-15 | Serono Lab | Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten |
| WO2005035771A2 (en) | 2003-10-10 | 2005-04-21 | Powderject Vaccines, Inc. | Nucleic acid constructs |
| EP2434020B1 (en) | 2004-01-22 | 2014-11-05 | Dnavec Research Inc. | Method of producing Paramyxoviridae viral vectors using a hybrid promoter comprising a cytomegalovirus enhancer and a chicken beta-actin promoter |
| WO2006111387A2 (en) | 2005-04-22 | 2006-10-26 | Lonza Biologics Plc. | Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene |
| AU2008262478B9 (en) | 2007-05-29 | 2014-06-19 | Aldevron, L.L.C. | Vectors and methods for genetic immunization |
| GB0710614D0 (en) | 2007-06-04 | 2007-07-11 | Lonza Biologics Plc | Mammalian expression vector with a highly efficient secretory signal sequence |
| US20120100573A1 (en) | 2010-10-21 | 2012-04-26 | Thudium Kent B | Cytomegalovirus intron a fragments |
| CN102392047B (zh) | 2011-11-11 | 2014-01-01 | 苏州工业园区晨健抗体组药物开发有限公司 | 一种适用于哺乳动物细胞的双顺反子表达载体及其应用 |
| HUE026516T2 (en) * | 2012-09-24 | 2016-06-28 | Lonza Biologics Plc | Expression vectors containing chimeric cytomegalovirus promoter and enhancer sequences |
-
2012
- 2012-09-24 HU HUE12185728A patent/HUE026516T2/en unknown
- 2012-09-24 ES ES12185728.8T patent/ES2540753T3/es active Active
- 2012-09-24 EP EP12185728.8A patent/EP2711426B1/en active Active
- 2012-09-24 PL PL12185728T patent/PL2711426T3/pl unknown
- 2012-09-24 DK DK12185728.8T patent/DK2711426T3/en active
-
2013
- 2013-09-23 CN CN201380049575.6A patent/CN104718296B/zh active Active
- 2013-09-23 JP JP2015532436A patent/JP6162246B2/ja active Active
- 2013-09-23 MX MX2015002888A patent/MX371007B/es active IP Right Grant
- 2013-09-23 TR TR2018/16314T patent/TR201816314T4/tr unknown
- 2013-09-23 TW TW102134171A patent/TWI507526B/zh active
- 2013-09-23 ES ES13773651.8T patent/ES2694778T3/es active Active
- 2013-09-23 WO PCT/EP2013/069715 patent/WO2014044845A1/en not_active Ceased
- 2013-09-23 SG SG11201502243YA patent/SG11201502243YA/en unknown
- 2013-09-23 EA EA201590264A patent/EA033008B1/ru not_active IP Right Cessation
- 2013-09-23 AU AU2013320157A patent/AU2013320157B2/en active Active
- 2013-09-23 KR KR1020157006996A patent/KR101757083B1/ko active Active
- 2013-09-23 US US14/426,329 patent/US9777290B2/en active Active
- 2013-09-23 PL PL13773651T patent/PL2898077T3/pl unknown
- 2013-09-23 EP EP13773651.8A patent/EP2898077B1/en active Active
- 2013-09-23 CA CA2880750A patent/CA2880750C/en active Active
- 2013-09-23 DK DK13773651.8T patent/DK2898077T3/en active
- 2013-09-23 BR BR112015005604-0A patent/BR112015005604B1/pt active IP Right Grant
- 2013-09-23 HU HUE13773651A patent/HUE040463T2/hu unknown
-
2015
- 2015-02-10 IL IL237171A patent/IL237171B/en active IP Right Grant
-
2017
- 2017-03-28 JP JP2017063537A patent/JP2017136081A/ja active Pending
- 2017-08-28 US US15/687,835 patent/US10294491B2/en active Active
-
2019
- 2019-04-02 US US16/372,738 patent/US20200002721A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015002888A (es) | Vectores de expresion que comprenden un promotor de citomegalovirus quimerico y secuencias mejoradas. | |
| BR112016029178A2 (pt) | composições e métodos para a expressão de rnas guia de crispr usando o promotor h1 | |
| PH12018501396A1 (en) | Plant regulatory elements and uses thereof | |
| UY35724A (es) | ?construcciones para expresar transgenes usando elementos reguladores de genes de ubiquitina de panicum?. | |
| IN2014DN03419A (es) | ||
| MX2013014544A (es) | Vectorales de terapia genica para adrenoleucodistrofia y adrenomieloneuropatia. | |
| PH12014500348A1 (en) | Genes and proteins for alkanoyl-coa synthesis | |
| MX2014004598A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| MX354704B (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| BR112015013029A2 (pt) | promotores e terminadores de tetraselmis para uso em células eucarióticas | |
| MX369726B (es) | Polipéptidos con actividad proteasa. | |
| MX353959B (es) | Metodo de floculacion. | |
| MX2013008507A (es) | Uso del promotor rd29 o fragmentos del mismo para expresion de transgenes inducible por estres en algodon. | |
| MX344356B (es) | Promotores preferidos para raices y metodos de uso. | |
| PH12014501554A1 (en) | Compositions and methods for the expression of a sequence in a reproductive tissue of a plant | |
| CR20200121A (es) | Elementos regulatorios de planta y sus usos (divisional 2015-0554) | |
| EA033437B1 (ru) | Fc-гамма-рецептор iib и его применение для лечения или предупреждения воспалительных и/или аутоиммунных заболеваний | |
| MX365947B (es) | Operaciones de cosecha mejoradas para proteinas recombinadas. | |
| IN2014CN03187A (es) | ||
| IN2015DN00205A (es) | ||
| MX2017012936A (es) | Promotor de plantas para la expresion transgenica. | |
| CA2923629A1 (en) | Plant regulatory elements and methods of use thereof | |
| NZ750842A (en) | Plant regulatory elements and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |